2016
The Use of Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML): Clinical Outcomes and Their Predictors in a Large International Patient Cohort
Stahl M, Podoltsev N, DeVeaux M, Perreault S, Itzykson R, Ritchie E, Sekeres M, Fathi A, Komrokji R, Bhatt V, Al-Kali A, Cluzeau T, Santini V, Brunner A, Roboz G, Fenaux P, Litzow M, Vey N, Verma V, Germing U, Fernández P, Zelterman D, Kim T, Prebet T, Gore S, Zeidan A. The Use of Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML): Clinical Outcomes and Their Predictors in a Large International Patient Cohort. Blood 2016, 128: 1063. DOI: 10.1182/blood.v128.22.1063.1063.Peer-Reviewed Original ResearchMultivariable logistic regression modelRR-AMLMinority of patientsOverall survivalPrior linesHypomethylating agentHMA therapyMedian numberLogistic regression modelsChromosome 7 abnormalitiesStable diseaseBlast percentageHematologic improvementProgressive diseaseHazard ratioClinical outcomesSpeakers bureauMultivariable Cox proportional hazards modelsPeripheral blood blast percentageRefractory acute myeloid leukemiaAllogeneic stem cell transplantationInternational Working Group criteriaWhite blood cell countCox proportional hazards modelBM blast percentage
2000
Granulocyte-Macrophage Colony-Stimulating Factor Priming plus Papillomavirus E6 DNA Vaccination: Effects on Papilloma Formation and Regression in the Cottontail Rabbit Papillomavirus-Rabbit Model
Leachman S, Tigelaar R, Shlyankevich M, Slade M, Irwin M, Chang E, Wu T, Xiao W, Pazhani S, Zelterman D, Brandsma J. Granulocyte-Macrophage Colony-Stimulating Factor Priming plus Papillomavirus E6 DNA Vaccination: Effects on Papilloma Formation and Regression in the Cottontail Rabbit Papillomavirus-Rabbit Model. Journal Of Virology 2000, 74: 8700-8708. PMID: 10954571, PMCID: PMC116381, DOI: 10.1128/jvi.74.18.8700-8708.2000.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBiopsyCottontail rabbit papillomavirusDisease Models, AnimalDisease-Free SurvivalDNA, ViralGene Transfer TechniquesGenetic VectorsGranulocyte-Macrophage Colony-Stimulating FactorImmunohistochemistryIn Situ HybridizationPapillomaPapillomavirus InfectionsRabbitsTumor Virus InfectionsVaccines, DNAViral VaccinesConceptsGM-CSF primingGM-CSF treatmentDNA vaccinationDNA inoculationPapilloma formationGM-CSFProfessional antigen-presenting cellsMajor histocompatibility complex classDisease-free survivalVaccination-challenge experimentsAntigen-presenting cellsII-positive cellsGranulocyte-macrophage colony-stimulating factorHistocompatibility complex classColony-stimulating factorGranulocyte-macrophage colonyPapilloma volumeVaccination regimenClinical outcomesCutaneous sitesDNA vaccineViral challengePapilloma growthControl rabbitsCombination treatment